ESP Pharma Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 80

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $486M

ESP Pharma General Information

Description

Developer of specialty pharmaceutical products designed to enhance the quality of therapeutics available to healthcare professionals. The company's specialty pharmaceutical products include therapeutics for high blood pressure and angina and late-stage development specialty drugs for bone marrow transplants, enabling patients to achieve improved outcomes in the acute-care setting.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • 2035 Lincoln Highway
  • Suite 2150
  • Edison, NJ 08817
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ESP Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 24-Mar-2005 $486M 0000 00000 Completed Profitable
3. Debt - General 08-Oct-2003 0000 0000 Completed Profitable
2. Early Stage VC (Series B) 16-Apr-2003 $28M Completed Profitable
1. Early Stage VC (Series A) 01-Apr-2002 $28M $28M Completed Profitable
To view ESP Pharma’s complete valuation and funding history, request access »

ESP Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ESP Pharma Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alta Partners Venture Capital Minority 000 0000 000000 0
Apax Partners PE/Buyout Minority 000 0000 000000 0
Canterbury Capital (South Carolina) Venture Capital Minority 000 0000 000000 0
Cressey & Company PE/Buyout Minority 000 0000 000000 0
Domain Associates Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

ESP Pharma FAQs

  • When was ESP Pharma founded?

    ESP Pharma was founded in 2000.

  • Who is the founder of ESP Pharma?

    John Spitznagel and Howard Weisman are the founders of ESP Pharma.

  • Where is ESP Pharma headquartered?

    ESP Pharma is headquartered in Edison, NJ.

  • What is the size of ESP Pharma?

    ESP Pharma has 80 total employees.

  • What industry is ESP Pharma in?

    ESP Pharma’s primary industry is Pharmaceuticals.

  • Is ESP Pharma a private or public company?

    ESP Pharma is a Private company.

  • What is the current valuation of ESP Pharma?

    The current valuation of ESP Pharma is 00000.

  • What is ESP Pharma’s current revenue?

    The current revenue for ESP Pharma is 000000.

  • How much funding has ESP Pharma raised over time?

    ESP Pharma has raised $85M.

  • Who are ESP Pharma’s investors?

    Alta Partners, Apax Partners, Canterbury Capital (South Carolina), Cressey & Company, and Domain Associates are 5 of 9 investors who have invested in ESP Pharma.

  • When was ESP Pharma acquired?

    ESP Pharma was acquired on 24-Mar-2005.

  • Who acquired ESP Pharma?

    ESP Pharma was acquired by PDL Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »